IL17-producing CD161+ CCR6+T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation

被引:0
|
作者
van der Waart, A. B. [1 ]
van der Velden, W. J. F. M. [2 ]
van Halteren, A. G. S. [3 ]
Leenders, M. J. L. G. [1 ]
Feuth, T. [4 ]
Blijlevens, N. M. A. [2 ]
van der Voort, R. [1 ]
Dolstra, H. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands
[3] Leiden Univ, Dept Pediat, Immunol Lab, Med Ctr, Leiden, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:610 / 610
页数:1
相关论文
共 50 条
  • [21] Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Jianing Fu
    Jessica Heinrichs
    Xue-Zhong Yu
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 277 - 301
  • [22] Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Fu, Jianing
    Heinrichs, Jessica
    Yu, Xue-Zhong
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (04) : 277 - 301
  • [23] Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
    Toubai, Tomomi
    Paczesny, Sophie
    Shono, Yusuke
    Tanaka, Junji
    Lowler, Kathleen P.
    Malter, Chelsea T.
    Kasai, Masaharu
    Imamura, Masahiro
    CURRENT STEM CELL RESEARCH & THERAPY, 2009, 4 (04) : 252 - 259
  • [24] Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation
    Mohty, Mohamad
    Gaugler, Beatrice
    CYTOKINE & GROWTH FACTOR REVIEWS, 2008, 19 (01) : 53 - 63
  • [25] Microparticles for Diagnosis of Graft-Versus-Host Disease After Allogeneic Stem Transplantation
    Rank, Andreas
    Nieuwland, Rienk
    Toth, Bettina
    Pihusch, Verena
    Delker, Ruth
    Hiller, Erhard
    Kolb, Hans-Jochem
    Pihusch, Rudolf
    TRANSPLANTATION, 2011, 92 (02) : 244 - 250
  • [26] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Nassar, Amr
    Elgohary, Ghada
    Elhassan, Tusneem
    Nurgat, Zubeir
    Mohamed, Said Y.
    Aljurf, Mahmoud
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [27] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [28] Serum catalase to predict graft-versus-host disease after allogeneic stem cell transplantation
    Kircher, B.
    Schumacher, P.
    Clausen, J.
    Auberger, J.
    Nachbaur, D.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S118 - S118
  • [29] Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation
    Quellmann, Susanne
    Schwarzer, Guido
    Huebel, Kai
    Greb, Alexander
    Engert, Andreas
    Bohlius, Julia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03):
  • [30] Proteomic patterns and graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
    Chiusolo, P.
    Bellesi, S.
    Fanali, C.
    Giammarco, S.
    Sica, S.
    Inzitari, R.
    Iavarone, F.
    Leone, G.
    Castagnola, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S13 - S13